Biography

Lin has extensive experience in prosecuting patents in several technical areas including biotechnology, pharmaceuticals, chemistry, and advanced materials.

Lin's additional focuses include medical diagnostics, immunotherapeutics, drug formulation and delivery, nanotechnology, microfluidics, microscopy, chromatography, and industrial chemical and biochemical processes. Lin also provides opinions, litigation support, and patent strategic advice, and is experienced in patent due diligence and post-grant proceedings. Lin's practice focuses on providing efficient and insightful patent drafting and prosecution for universities, early-stage companies, and large corporations internationally.

Prior to practicing law, Lin had an academic research career in the U.S., Germany, and Austria, taught biophysics, physiology, and pharmacology, and was a grant review administrator at the National Institutes of Health. As a patent lawyer, Lin has more than 20 years of experience working at law firms in the Boston and Washington, D.C. areas, as well as serving as an in-house patent attorney at a major biotechnology company.

Lin plays classical guitar and is a member of the Boston Classical Guitar Society. He also enjoys listening to music, hiking, and traveling.

Services/Industries

Education

  • Georgetown University Law Center  (J.D.)
  • Vanderbilt University  (Ph.D.)
  • Tulane University  (B.S., summa cum laude)

Bar Admissions

  • Massachusetts
  • Maryland

Memberships

  • Member, Life Sciences Patent Network Connect

Court and Other Admissions

  • U.S. Patent and Trademark Office

Firm Highlights

News

Expanded 2024 Maine Diversity Summer Associate Program Now Accepting Applications

Matter

Elections and Constitutional Law: Successfully Challenged Certification of Initiative Petition

In a victory for consumers and the ride-hailing public, the Massachusetts Supreme Judicial Court recently barred the Secretary of State from placing on the November ballot initiative petitions proposed by companies such as Uber...

Publication/Podcast

Corporate Transparency Act—Considerations Affecting Entities That Are Exempt or Excluded from Reporting Company Status

The Corporate Transparency Act ( CTA ) takes effect starting January 1, 2024. The Act is administered by FinCEN , a bureau of U.S. Treasury charged with combatting money laundering and other financial crimes...

Publication/Podcast

Determining Whether Your Entity is a Reporting Company: Selected Issues

Under the Corporate Transparency Act ( CTA ), more than 30 million “ Reporting Companies ” will need to register with FinCEN (a bureau of the U.S. Treasury Department) and file Beneficial Ownership Information...

Matter

Successful Representation of Insurer before U.S. District Court for the District of Maine

Verrill successfully represented an insurer before the U.S. District Court for the District of Maine in an insurance coverage matter alleging that the insurer improperly denied a defense and indemnification to a landlord under...

Blog

HIPAA Privacy Rule Changes: Just in time for the New Year?

In 2021, the Department of Health and Human Services (HHS) proposed changes to the Privacy Rule under the Health Insurance Portability and Accessibility Act of 1996 (HIPAA) that would significantly alter the current regulations...

Blog

HR Power Hour with Heather Hansen

News

Verrill Recognized Nationally for Health Care, Land Use and Zoning, Commercial Litigation, Real Estate, and Trust & Estates by Best Lawyers®

Blog

The Donation Sweepstakes

Tis the season. Some people like to use the phrase “Doing Well by Doing Good.” Early U.S. business magnates knew that financial benefits can come from philanthropy. In 1888, Cornealius Vanderbilt donated $250,000 (that’s...

Event

Annual Employment Law Update

More details coming soon!

Contact Verrill at (855) 307 0700